Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



GAYNOR RICHARD Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 4 GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.
Txns: Paid exercise price by delivering 1,430 shares @ $29.88, valued at $42.7k
Exercised 5,957 options to buy @ $0
06/30/2023 4 GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 12,732 options to buy @ $31.33, valued at $398.9k
Granted 5,985 options to buy @ $0
06/30/2023 4 GAYNOR RICHARD (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 18,903 shares @ $26.45, valued at $500k
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2021 4 GAYNOR RICHARD (Director) has filed a Form 4 on Zai Lab Ltd
Txns: Granted 8,912 shares @ $0
11/22/2021 3 GAYNOR RICHARD (Director) has filed a Form 3 on Zai Lab Ltd
06/16/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/11/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/04/2020 4 GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 11,509 options to buy @ $18.82, valued at $216.6k
Granted 5,578 options to buy @ $0
05/22/2020 4 GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 12,823 options to buy @ $16.85, valued at $216.1k
Granted 6,104 options to buy @ $0
05/06/2020 4 GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Disposed/sold 210,410 shares @ $0
Disposed/sold 58,005 options to buy @ $10.2, valued at $591.7k
Disposed/sold 105,000 options to buy @ $6.13, valued at $643.7k
Disposed/sold 155,373 options to buy @ $2.65, valued at $411.7k
03/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
03/02/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/13/2020 4 GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Granted 65,000 shares @ $0
12/09/2019 4 GAYNOR RICHARD (Director) has filed a Form 4 on Alkermes plc.
Txns: Granted 11,200 options to buy @ $21.23, valued at $237.8k
Granted 61,800 options to buy @ $21.23, valued at $1.3M
11/27/2019 4 GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Sold 20,000 shares @ $1.3749, valued at $27.5k
Sold 23,000 shares @ $1.3144, valued at $30.2k
Sold 22,322 shares @ $1.2384, valued at $27.6k
11/25/2019 4 GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Granted 75,000 shares @ $0
09/24/2019 3 GAYNOR RICHARD (Director) has filed a Form 3 on Alkermes plc.
09/24/2019 3 GAYNOR RICHARD (Director) has filed a Form 3 on Alkermes plc.
03/01/2019 4 GAYNOR RICHARD (President of R&D) has filed a Form 4 on Neon Therapeutics, Inc.
Txns: Granted 57,500 shares @ $0
Granted 105,000 options to buy @ $6.13, valued at $643.7k
06/26/2018 3 GAYNOR RICHARD (President of R&D) has filed a Form 3 on Neon Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy